Apoptosis A Link between Cancer Genetics and Chemotherapy
By Ricky W. Johnstone, A. Ruefli, Scott W. Lowe. Cell, 2002
2,368 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/8e4ecb580db17292ed4a2ea5393ace0db5c84518
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
- Jerry M. Adams
- Scott W. Lowe
- Suzanne Cory
- Simon N. Willis
- J. Fridman
- C. Sherr
- M. Soengas
- F. McCormick
Citations in the corpus
- Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. (2003, background): “Failure to die results in the survival of cells harboring genetic mutations that may become cancerous (Johnstone et al. 2002).”
- Awareness and current knowledge of breast cancer (2017, background): “Chemotherapy The process of killing cancer cells by using certain medicines is termed as chemotherapy [202, 203].”
- Control of apoptosis by p53 (2003, background): “In addition to its role in suppressing tumorigenesis, p53-dependent apoptosis contributes to chemotherapyinduced cell death (see, for review, Johnstone et al., 2002).”
- The Bcl-2 family: roles in cell survival and oncogenesis (2003, background): “As impaired apoptosis plays a central role in the pathogenesis of many diseases, the search is accelerating for novel agents that engage the cell death machinery (Nicholson, 2000; Johnstone et al., 2002; Reed, 2002, 2003).”
- The Bcl-2 apoptotic switch in cancer development and therapy (2007, background): “Our laboratory discovered that Bcl-2 acts by promoting cell survival rather than by driving cell proliferation and proposed the concept, now widely accepted (Hanahan and Weinberg, 2000; Johnstone et al., 2002), that impairment of apoptosis is a critical step in tumor development (Vaux et al.”